Impact of COVID-19 on postgraduate education and mental wellbeing of surgical trainees:  a systematic review

Basnayake, Oshan; Jayarajah, Umesh; Gunawardena, K. A. N. N. P; Samarasekera, Dharmabandhu Nandadeva

doi:10.4038/sljs.v39i3.8888

Cited by 1 publication

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, healthcare workers were also affected because of increased high-risk exposures and the lack of clinical exposure/training due to the postponement of routine surgeries. 129 – 131 Surgery should not be delayed for HCC patients. However, adequate precautions should be taken to minimize complications, which include prior vaccination and proper timing if previously infected by SARS-CoV-2 and thromboprophylaxis.…”

Section: Covid-19 In Patients With Diagnosed Liver Diseasesmentioning

confidence: 99%

Involvement of the Liver in COVID-19: A Systematic Review

Kariyawasam

Jayarajah

Abeysuriya

et al. 2022

The American Journal of Tropical Medicine and Hygiene

Self Cite

View full text Add to dashboard Cite

COVID-19, a respiratory viral infection, has affected 388 million individuals worldwide as of the February 4, 2022. In this review, we have outlined the important liver manifestations of COVID-19 and discussed the possible underlying pathophysiological mechanisms and their diagnosis and management. Factors that may contribute to hepatic involvement in COVID-19 include direct viral cytopathic effects, exaggerated immune responses/systemic inflammatory response syndrome, hypoxia-induced changes, vascular changes due to coagulopathy, endothelitis, cardiac congestion from right heart failure, and drug-induced liver injury. The majority of COVID-19-associated liver symptoms are mild and self-limiting. Thus management is generally supportive. Liver function tests and abdominal imaging are the primary investigations done in relation to liver involvement in COVID-19 patients. However, imaging findings are nonspecific. Severe acute respiratory syndrome coronavirus 2 RNA has been found in liver biopsies. However, there is limited place for liver biopsy in the clinical context, as it does not influence management. Although, the management is supportive in the majority of patients without previous liver disease, special emphasis is needed in those with nonalcoholic fatty liver disease, cirrhosis, hepatocellular carcinoma, hepatitis B and C infections, and alcoholic liver disease, and in liver transplant recipients.

show abstract

Section: Covid-19 In Patients With Diagnosed Liver Diseasesmentioning

confidence: 99%